(Q33609513)

English

Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

Little enhancement of meal-induced glucagon-like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls (English)

1 reference

Europe PubMed Central

28 July 2017

Jens Juul Holst

9

0 references

object named as

Daisuke Yabe

1

0 references

Carolyn F. Deacon

object named as

Carolyn F Deacon

8

0 references

object named as

Nobuya Inagaki

11

0 references

author name string

Akira Kuroe

2

1 reference

Europe PubMed Central

28 July 2017

Soushou Lee

3

1 reference

Europe PubMed Central

28 July 2017

Koin Watanabe

4

1 reference

Europe PubMed Central

28 July 2017

Takanori Hyo

5

1 reference

Europe PubMed Central

28 July 2017

Masahiro Hishizawa

6

1 reference

Europe PubMed Central

28 July 2017

Takeshi Kurose

7

1 reference

Europe PubMed Central

28 July 2017

Tsutomu Hirano

10

1 reference

Europe PubMed Central

28 July 2017

Yutaka Seino

12

1 reference

Europe PubMed Central

28 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 April 2010

1 reference

Europe PubMed Central

28 July 2017

Journal of Diabetes Investigation

1 reference

Europe PubMed Central

28 July 2017

1

1 reference

Europe PubMed Central

28 July 2017

1-2

1 reference

Europe PubMed Central

28 July 2017

56-59

1 reference

Europe PubMed Central

28 July 2017

Immunoassays for the incretin hormones GIP and GLP-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020678

21 June 2018

Incretin-based therapies for type 2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020678

21 June 2018

Nutritional regulation of glucagon-like peptide-1 secretion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020678

21 June 2018

Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020678

21 June 2018

The Physiology of Glucagon-like Peptide 1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020678

21 June 2018

Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020678

21 June 2018

The biology of incretin hormones

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020678

21 June 2018

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020678

21 June 2018

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020678

21 June 2018

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020678

21 June 2018

Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide.

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2010.00010.X

21 January 2018

Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2010.00010.X

21 January 2018

Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2010.00010.X

21 January 2018

Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake.

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2010.00010.X

21 January 2018

Vildagliptin dose-dependently improves glycemic control in Japanese patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2010.00010.X

21 January 2018

Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2010.00010.X

21 January 2018

Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia or weight gain: A double-blind, randomized, controlled trial in Japanese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2010.00010.X

21 January 2018

Incretin and islet hormonal responses to fat and protein ingestion in healthy men.

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2010.00010.X

21 January 2018

Secretion, degradation, and elimination of glucagon-like peptide 1 and gastric inhibitory polypeptide in patients with chronic renal insufficiency and healthy control subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2010.00010.X

21 January 2018

Postprandial glucose, insulin, and incretin responses to grain products in healthy subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020678

30 October 2018

Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020678

30 October 2018

The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera

1 reference

https://api.crossref.org/works/10.1111%2FJ.2040-1124.2010.00010.X

21 January 2018

Incretin effect due to increased secretion and decreased clearance of insulin in normal humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/24843409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/24843409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced incretin effect in type 2 (non-insulin-dependent) diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/24843409

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.2040-1124.2010.00010.X

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33609513&oldid=1622672432"